The overall goal of this program is to conduct investigations into the molecular mechanisms of lymphocyte activation in the hopes that this knowledge will be applicable to clinical issues related to the treatment of cancer. This goal will be addressed by the integrated efforts of three independent investigators who are attacking the scientific issues from a number of perspectives. The first project describes experiments investigating the molecular biology and biochemistry of how the CD45 tyrosine phosphatase functions to regulate signal transduction via the T cell and B cell antigen receptors and how CD45 may function also in signaling via CD4O. Experiments are described which probe the molecular basis of the relationship between CD45 and other cellular proteins and investigate the physiological relevance of these interactions. Additional experiments are described designed to identify phosphotyrosine containing proteins important in coupling signaling pathways after T cell receptor ligation. The second project of this proposal examines the structure/function relationships of CD4O as a signal transduction molecule expressed on the surface of B lymphocytes. Major focus of this project is to follow up on a novel observation suggesting that expression of CD4O on the surface of lymphocytes impacts significantly on signal transduction via another cell surface receptor, Fas. The third project examines the molecular biology and biochemistry of oligodeoxynucleotide- (ODN) mediated stimulation of B lymphocytes. These experiments are designed to understand better the signaling events which occur after ODN treatment of B cells and to determine what molecules in the B cells interact directly with these novel stimulatory agents. The work proposed by each project leader will be facilitated by an Administrative Core and a scientific core, the Signal Transduction Assay Core. The three projects and the two cores will take full advantage of the skills and experience of the individual project leaders and are mutually supportive; both intellectually and technically. As our laboratories have developed closer working relationships, we have discovered that our collaborative efforts are synergistic rather than merely additive. Formal integration of our efforts into this program will cement our collaborations and lead to increased productivity for each laboratory and a richer environment for our trainees.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA066570-05
Application #
6172303
Study Section
Cancer Centers and Research Programs Review Committee (CCRP)
Program Officer
Mccarthy, Susan A
Project Start
1996-07-25
Project End
2002-06-30
Budget Start
2000-07-01
Budget End
2002-06-30
Support Year
5
Fiscal Year
2000
Total Cost
$775,458
Indirect Cost
Name
University of Pennsylvania
Department
Pathology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Sonnenberg, Gregory F; Mangan, Paul R; Bezman, Natalie A et al. (2010) Mislocalization of SLP-76 leads to aberrant inflammatory cytokine and autoantibody production. Blood 115:2186-95
Zhu, Nongliao; Ramirez, Luis M; Lee, Rosaline L et al. (2002) CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-kappa B pathway. J Immunol 168:744-54
Hostager, Bruce S; Bishop, Gail A (2002) Role of TNF receptor-associated factor 2 in the activation of IgM secretion by CD40 and CD120b. J Immunol 168:3318-22
Shen, Weiyin; Waldschmidt, Marianella; Zhao, Xiuqin et al. (2002) Antitumor mechanisms of oligodeoxynucleotides with CpG and polyG motifs in murine prostate cancer cells: decrease of NF-kappaB and AP-1 binding activities and induction of apoptosis. Antisense Nucleic Acid Drug Dev 12:155-64
Brown, Kevin D; Hostager, Bruce S; Bishop, Gail A (2002) Regulation of TRAF2 signaling by self-induced degradation. J Biol Chem 277:19433-8
Bishop, G A; Ramirez, L M; Baccam, M et al. (2001) The immune response modifier resiquimod mimics CD40-induced B cell activation. Cell Immunol 208:9-17
Brown, K D; Hostager, B S; Bishop, G A (2001) Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J Exp Med 193:943-54
Catlett, I M; Xie, P; Hostager, B S et al. (2001) Signaling through MHC class II molecules blocks CD95-induced apoptosis. J Immunol 166:6019-24
Busch, L K; Bishop, G A (2001) Multiple carboxyl-terminal regions of the EBV oncoprotein, latent membrane protein 1, cooperatively regulate signaling to B lymphocytes via TNF receptor-associated factor (TRAF)-dependent and TRAF-independent mechanisms. J Immunol 167:5805-13
Myers, L P; Krieg, A M; Pruett, S B (2001) Bacterial DNA does not increase serum corticosterone concentration or prevent increases induced by other stimuli. Int Immunopharmacol 1:1605-14

Showing the most recent 10 out of 37 publications